Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | PGR | P06401 | 3/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.32 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17153640 | 1.00 | PDK2 (0.34) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL15495760 | 0.99 | SIGMAR1 (0.34) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL17153638 | 0.99 | PDK2 (0.35) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL16922970 | 0.99 | PDK2 (0.35) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL17153708 | 0.99 | PDK2 (0.35) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL16366592 | 0.99 | PDK2 (0.35) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL17153704 | 0.99 | PDK2 (0.35) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL20470710 | 0.98 | SIGMAR1 (0.34) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL15495893 | 0.98 | SIGMAR1 (0.33) | PDK2SIGMAR1CA12CA1CA2 | |
| SCHEMBL18436006 | 0.98 | SIGMAR1 (0.33) | PDK2SIGMAR1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9871203-B2 | Aromatic amine derivative, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-9871203-B2 | Aromatic amine derivative, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20150287921-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| US-20150287921-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150287921-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | RER1, AFF1, ESR2 | PDK2 3794/4885SIGMAR1 1356/4885CA12 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.